Correlation Between Axsome Therapeutics and PDS Biotechnology
Can any of the company-specific risk be diversified away by investing in both Axsome Therapeutics and PDS Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Axsome Therapeutics and PDS Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Axsome Therapeutics and PDS Biotechnology Corp, you can compare the effects of market volatilities on Axsome Therapeutics and PDS Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Axsome Therapeutics with a short position of PDS Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Axsome Therapeutics and PDS Biotechnology.
Diversification Opportunities for Axsome Therapeutics and PDS Biotechnology
-0.5 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Axsome and PDS is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Axsome Therapeutics and PDS Biotechnology Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PDS Biotechnology Corp and Axsome Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Axsome Therapeutics are associated (or correlated) with PDS Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PDS Biotechnology Corp has no effect on the direction of Axsome Therapeutics i.e., Axsome Therapeutics and PDS Biotechnology go up and down completely randomly.
Pair Corralation between Axsome Therapeutics and PDS Biotechnology
Given the investment horizon of 90 days Axsome Therapeutics is expected to generate 0.47 times more return on investment than PDS Biotechnology. However, Axsome Therapeutics is 2.13 times less risky than PDS Biotechnology. It trades about 0.1 of its potential returns per unit of risk. PDS Biotechnology Corp is currently generating about -0.03 per unit of risk. If you would invest 7,676 in Axsome Therapeutics on August 24, 2024 and sell it today you would earn a total of 2,143 from holding Axsome Therapeutics or generate 27.92% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Axsome Therapeutics vs. PDS Biotechnology Corp
Performance |
| Timeline |
| Axsome Therapeutics |
| PDS Biotechnology Corp |
Axsome Therapeutics and PDS Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Axsome Therapeutics and PDS Biotechnology
The main advantage of trading using opposite Axsome Therapeutics and PDS Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Axsome Therapeutics position performs unexpectedly, PDS Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PDS Biotechnology will offset losses from the drop in PDS Biotechnology's long position.| Axsome Therapeutics vs. ZyVersa Therapeutics | Axsome Therapeutics vs. Sonnet Biotherapeutics Holdings | Axsome Therapeutics vs. Zura Bio Limited | Axsome Therapeutics vs. Phio Pharmaceuticals Corp |
| PDS Biotechnology vs. Mereo BioPharma Group | PDS Biotechnology vs. Terns Pharmaceuticals | PDS Biotechnology vs. Inozyme Pharma | PDS Biotechnology vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |